Fluconazole in cats: Pharmacokinetics following intravenous and oral administration and penetration into cerebrospinal fluid, aqueous humour and pulmonary epithelial lining fluid

被引:35
作者
Vaden, SL
Heit, MC
Hawkins, EC
Manaugh, C
Riviere, JE
机构
[1] WYETH AYERST RES,PHARMACEUT SCI,BIOPHARM SECT,ROUSES POINT,NY 12979
[2] N CAROLINA STATE UNIV,COLL VET MED,DEPT ANAT PHYSIOL SCI & RADIOL,RALEIGH,NC 27606
关键词
D O I
10.1111/j.1365-2885.1997.tb00093.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of fluconazole following intravenous (i.v.) and oral (p.o.) administration and the penetration of fluconazole into cerebrospinal fluid, aqueous humour and epithelial lining fluid (ELF) of the lungs were evaluated in adult male cats. Pharmacokinetic parameters were calculated from serum concentration-time data obtained following i.v. and p.o. administration of 50 mg per cat using a cross-over study design. Fluconazole concentrations were measured using a high-performance liquid chromatography assay. Mean total body clearance of fluconazole was 37.7 mL/h.kg, mean volume of distribution at steady state was 1.14 L/kg, mean residence time was 31.0 h and mean half-life of elimination was 25 h as derived by non-compartmental analysis of data. Absorption was complete. Mean ratios of fluid:serum fluconazole concentrations following administration of 50 mg fluconazole per day for 8 days were as follows: cerebrospinal fluid, 0.88; aqueous humour 0.79; ELF, 1.20. Fluconazole concentrations in cerebrospinal fluid, aqueous humour and ELF exceeded reported minimum inhibitory concentrations of fluconazole far pathogenic fungi. Results of this study suggest fluconazole can effectively be administered to cats at 50 mg per cat per day.
引用
收藏
页码:181 / 186
页数:6
相关论文
共 31 条
[1]  
ARNDT CA, 1988, J INFECT DIS, V157, P8
[2]   BRONCHOALVEOLAR DISTRIBUTION OF CEFUROXIME AXETIL AND INVITRO EFFICACY OF OBSERVED CONCENTRATIONS AGAINST RESPIRATORY PATHOGENS [J].
BALDWIN, DR ;
ANDREWS, JM ;
WISE, R ;
HONEYBOURNE, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (03) :377-385
[3]  
BALDWIN DR, 1990, EUR RESPIR J, V3, P886
[4]   THE PENETRATION OF CEFPIROME INTO THE POTENTIAL SITES OF PULMONARY INFECTION [J].
BALDWIN, DR ;
MAXWELL, SRJ ;
HONEYBOURNE, D ;
ANDREWS, JM ;
ASHBY, JP ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (01) :79-86
[5]  
Brammer K.W., 1990, REV INFECT DIS S3, V12, P318
[6]  
Brooks D. E., 1991, Progress in Veterinary and Comparative Ophthalmology, V1, P263
[7]   PHARMACOKINETICS OF FLUCONAZOLE IN CATS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION [J].
CRAIG, AJ ;
RAMZAN, I ;
MALIK, R .
RESEARCH IN VETERINARY SCIENCE, 1994, 57 (03) :372-376
[8]   CLINICAL PHARMACOKINETICS OF FLUCONAZOLE [J].
DEBRUYNE, D ;
RYCKELYNCK, JP .
CLINICAL PHARMACOKINETICS, 1993, 24 (01) :10-27
[9]   SPUTUM LEVELS OF FLUCONAZOLE IN HUMANS [J].
EBDEN, P ;
NEILL, P ;
FARROW, PR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :963-964
[10]   FLUCONAZOLE PENETRATION INTO CEREBROSPINAL-FLUID IN HUMANS [J].
FOULDS, G ;
BRENNAN, DR ;
WAJSZCZUK, C ;
CATANZARO, A ;
GARG, DC ;
KNOPF, W ;
RINALDI, M ;
WEIDLER, DJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (04) :363-366